injecting dexmedetomidineinjecting mixture of bupivacaine fentanyl
injecting dexmedetomidine: injecting dexmedetomidine intrathecally during labour pain
injecting mixture of bupivacaine fentanyl: injecting mixture of bupivacaine fentanyl intrathecally
Study summary
To evaluate the efficacy and safety of dexmedetomidine as an adjuvant to bupivacain and fentanyl in spinal Analgesia to decreases pain during normal labour
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria:
Age of patint is between 18 and 40 years. gestational age of fetus is more than 37 weeks. singleton viable fetus and cephalic presentation. spontaneous labor with cervix dilation more than 5cm.
Exclusion Criteria:
Drug allergy. Blood Disease. Infection at site of injection. patient takes anticoagulants. patient has pre-eclampsia ,cardiac disease (NYHA III-IV) or diabetes mellitus type I prior to the pregnancy patients refuse
Primary outcome measure(s)
changes in numeric pain intensity score ( NPSI) maximum 10 minimum 0 — baseline evaluate the safety and effecacy of dexmetomidine for labour pain by numeric pain intensity score maximum 10 ( sever pain ), minimum 0 ( no pain )
duration of sensory blockade — 5 minutes after injection of analgesic agents till normal delivery done change in numeric pain intensity score ( NPIS )
changes in numeric pain intensity score ( NPIS ) — 5 minutes, 10 minutes, 15 minutes, 30 minutes and 45 minintes after injection of analgesic agents Scores range from 0-10 points, maximum ( 10 ) means sever pain, minimum ( 0 ) means no pain
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.